Nitric oxide enhances Th9 cell differentiation and airway inflammation

Nature Communications

Volumn 5, Issue , 2014, Pages

  Niedbala, Wanda ^a   Besnard, Anne Gaelle ^a   Nascimento, Daniele Carvalho ^a,b   Donate, Paula Barbim ^b   Sonego, Fabiane ^a   Yip, Edwin ^a   Guabiraba, Rodrigo ^a   Chang, Hyun Dong ^c   Fukada, Sandra Y ^a   Salmond, Robert J ^a   Schmitt, Edgar ^d   Bopp, Tobias ^d   Ryffel, Bernhard ^e,f   Liew, Foo Y ^a,g,h  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Leibniz Institute   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e UNIVERSITÉ D'ORLÉANS   (France)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^h MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 2; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 9; NITRIC OXIDE; PROTEIN MDM2; PROTEIN P53; STAT5 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; NOS2 PROTEIN, HUMAN; NOS2 PROTEIN, MOUSE;

GENE EXPRESSION; NITRIC OXIDE; POLARIZATION; PUBLIC HEALTH; RODENT; TUMOR;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC DISEASE; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL TRANSFER; CONTROLLED STUDY; DOWN REGULATION; ENZYME MECHANISM; EOSINOPHILIA; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NITROSYLATION; NONHUMAN; OOCYTE; POLARIZATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT INFLAMMATION; TH17 CELL; TH9 CELL; TUMOR SUPPRESSOR GENE; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CELL SEPARATION; CHEMICALLY INDUCED; CHEMISTRY; CYTOLOGY; FLOW CYTOMETRY; INFLAMMATION; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; EOSINOPHILIA; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTORS; INTERLEUKIN-2; INTERLEUKIN-9; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; STAT5 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84907365249     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5575     Document Type: Article

References (65)

1. O'Shea, J. J., Hunter, C. A. & Germain, R. N. T cell heterogeneity: firmly fixed, predominantly plastic or merely malleable? Nat. Immunol. 9, 450-453 (2008). (Pubitemid 351560508)
2. Dardalhon, V. et al. IL-4 inhibits TGF-beta-induced Foxp3\+ T cells and, together with TGF-beta, generates IL-9\+ IL-10\+ Foxp3(-) effector T cells. Nat. Immunol. 9, 1347-1355 (2008).
3. Veldhoen, M. et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341-1346 (2008).
4. Chang, H. C. et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11, 527-534 (2010).
5. Staudt, V. et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33, 192-202 (2010).
6. Faulkner, H., Humphreys, N., Renauld, J. C., Van Snick, J. & Grencis, R. Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur. J. Immunol. 27, 2536-2540 (1997). (Pubitemid 27453841)
7. Faulkner, H., Renauld, J. C., Van Snick, J. & Grencis, R. K. Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris. Infect. Immun. 66, 3832-3840 (1998). (Pubitemid 28347844)
8. Khan, W. I. et al. Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections. Infect. Immun. 71, 2430-2438 (2003). (Pubitemid 36519854)
9. Temann, U. A., Geba, G. P., Rankin, J. A. & Flavell, R. A. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 188, 1307-1320 (1998). (Pubitemid 28478019)
10. Temann, U. A., Ray, P. & Flavell, R. A. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 109, 29-39 (2002). (Pubitemid 34052539)
11. Shimbara, A. et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J. Allergy Clin. Immunol. 105, 108-115 (2000). (Pubitemid 30059110)
12. Jones, C. P., Gregory, L. G., Causton, B., Campbell, G. A. & Lloyd, C. M. Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology. J. Allergy Clin. Immunol. 129, 1000-1010e1003 (2012).
13. Schmitt, E. et al. IL-9 production of naive CD4\+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J. Immunol. 153, 3989-3996 (1994).
14. Helmby, H. & Grencis, R. K. Interleukin 1 plays a major role in the development of Th2-mediated immunity. Eur. J. Immunol. 34, 3674-3681 (2004). (Pubitemid 40012185)
15. Schmitt, E. et al. IL-1 serves as a secondary signal for IL-9 expression. J. Immunol. 147, 3848-3854 (1991).
16. Angkasekwinai, P., Chang, S. H., Thapa, M., Watarai, H. & Dong, C. Regulation of IL-9 expression by IL-25 signaling. Nat. Immunol. 11, 250-256 (2010).
17. Bogdan, C., Rollinghoff, M. & Diefenbach, A. The role of nitric oxide in innate immunity. Immunol. Rev. 173, 17-26 (2000). (Pubitemid 30095207)
18. Liew, F. Y. Regulation of lymphocyte functions by nitric oxide. Curr. Opin. Immunol. 7, 396-399 (1995).
19. Moncada, S. & Higgs, A. The L-arginine-nitric oxide pathway. New Engl. J. Med. 329, 2002-2012 (1993). (Pubitemid 24015045)
20. Nathan, C. F. & Hibbs, Jr J. B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3, 65-70 (1991).
21. Niedbala, W. et al. Regulation of type 17 helper T-cell function by nitric oxide during inflammation. Proc. Natl Acad. Sci. USA 108, 9220-9225 (2011).
22. Frank, D. A., Robertson, M. J., Bonni, A., Ritz, J. & Greenberg, M. E. Interleukin 2 signaling involves the phosphorylation of Stat proteins. Proc. Natl Acad. Sci. USA 92, 7779-7783 (1995).
23. Gaffen, S. L. et al. Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity. Proc. Natl Acad. Sci. USA 92, 7192-7196 (1995).
24. Gilmour, K. C., Pine, R. & Reich, N. C. Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc. Natl Acad. Sci. USA 92, 10772-10776 (1995).
25. Hou, J., Schindler, U., Henzel, W. J., Wong, S. C. & McKnight, S. L. Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity 2, 321-329 (1995).
26. Lin, J. X. et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2, 331-339 (1995).
27. Yao, W. et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 38, 360-372 (2013).
28. Niedbala, W. et al. Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP. Proc. Natl Acad. Sci. USA 99, 16186-16191 (2002). (Pubitemid 35462770)
29. Niedbala, W. et al. Nitric oxide induces CD4\+CD25\+ Foxp3 regulatory T cells from CD4\+CD25 T cells via p53, IL-2, and OX40. Proc. Natl Acad. Sci. USA 104, 15478-15483 (2007).
30. Oren, M. Regulation of the p53 tumor suppressor protein. J. Biol. Chem. 274, 36031-36034 (1999).
31. Woods, D. B. & Vousden, K. H. Regulation of p53 function. Exp. Cell Res. 264, 56-66 (2001). (Pubitemid 32989081)
32. Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299 (1997). (Pubitemid 27220766)
33. Honda, R., Tanaka, H. & Yasuda, H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25-27 (1997). (Pubitemid 28037193)
34. Kubbutat, M. H., Jones, S. N. & Vousden, K. H. Regulation of p53 stability by Mdm2. Nature 387, 299-303 (1997). (Pubitemid 27220767)
35. Momand, J., Zambetti, G. P., Olson, D. C., George, D. & Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245 (1992).
36. Forrester, M. T., Foster, M. W. & Stamler, J. S. Assessment and application of the biotin switch technique for examining protein S-nitrosylation under conditions of pharmacologically induced oxidative stress. J. Biol. Chem. 282, 13977-13983 (2007). (Pubitemid 47100466)
37. Kaplan, M. H., Schindler, U., Smiley, S. T. & Grusby, M. J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313-319 (1996). (Pubitemid 26132509)
38. Shimoda, K. et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630-633 (1996).
39. Takeda, K. et al. Essential role of Stat6 in IL-4 signalling. Nature 380, 627-630 (1996).
40. Wilhelm, C. et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 12, 1071-1077 (2011).
41. Salmond, R. J. et al. IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin. J. Allergy Clin. Immunol. 130, 1159-1166e1156 (2012).
42. Yang, X. O. et al. The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation. Nat. Immunol. 14, 732-740 (2013).
43. Goswami, R. & Kaplan, M. H. Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells. J. Immunol. 189, 3026-3033 (2012).
44. Bessoles, S. et al. IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro-and anti-inflammatory cytokines. J. Leukoc. Biol. 84, 224-233 (2008). (Pubitemid 351960298)
45. Xiao, X. et al. OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat. Immunol. 13, 981-990 (2012).
46. Laurence, A. et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381 (2007). (Pubitemid 46413906)
47. Kerzerho, J. et al. Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity. J. Allergy Clin. Immunol. 131, 1048-1057 (2013).
48. Keefer, L. K., Nims, R. W., Davies, K. M. & Wink, D. A. 'NONOates' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 268, 281-293 (1996). (Pubitemid 26286370)
49. Macphail, S. E. et al. Nitric oxide regulation of human peripheral blood mononuclear cells: critical time dependence and selectivity for cytokine versus chemokine expression. J. Immunol. 171, 4809-4815 (2003).
50. Okuda, Y., Sakoda, S., Fujimura, H. & Yanagihara, T. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 73, 107-116 (1997). (Pubitemid 27105276)
51. Staykova, M. A., Paridaen, J. T., Cowden, W. B. & Willenborg, D. O. Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis. Am. J. Pathol. 166, 147-157 (2005). (Pubitemid 40051668)
52. Hohlfeld, J. M., Schmiedl, A., Erpenbeck, V. J., Venge, P. & Krug, N. Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma. J. Allergy Clin. Immunol. 113, 496-502 (2004). (Pubitemid 38338956)
53. Toda, M., Tulic, M. K., Levitt, R. C. & Hamid, Q. A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J. Allergy Clin. Immunol. 109, 246-250 (2002). (Pubitemid 34158288)
54. Ying, S., Meng, Q., Kay, A. B. & Robinson, D. S. Elevated expression of interleukin-9 mRNA in the bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes. Clin. Exp. Allergy. 32, 866-871 (2002). (Pubitemid 34626084)
55. Parker, J. M. et al. Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma. BMC Pulm. Med. 11, 14 (2011).
56. Robbins, R. A. et al. Expression of inducible nitric oxide in human lung epithelial cells. Biochem. Biophys. Res. Commun. 203, 209-218 (1994). (Pubitemid 24281081)
57. Kharitonov, S. A. et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343, 133-135 (1994). (Pubitemid 24028638)
58. Persson, M. G., Zetterstrom, O., Agrenius, V., Ihre, E. & Gustafsson, L. E. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 343, 146-147 (1994). (Pubitemid 24028642)
59. Barnes, P. J. & Liew, F. Y. Nitric oxide and asthmatic inflammation. Immunol. Today 16, 128-130 (1995).
60. Smith, A. D. et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am. J. Respir. Crit. Care. Med. 169, 473-478 (2004). (Pubitemid 38187119)
61. Smith, A. D. et al. Exhaled nitric oxide: a predictor of steroid response. Am. J. Respir. Crit. Care. Med. 172, 453-459 (2005). (Pubitemid 41117391)
62. Hahn, P. Y., Morgenthaler, T. Y. & Lim, K. G. Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough. Mayo. Clin. Proc. 82, 1350-1355 (2007). (Pubitemid 350060130)
63. Hogman, M., Frostell, C. G., Hedenstrom, H. & Hedenstierna, G. Inhalation of nitric oxide modulates adult human bronchial tone. Am. Rev. Respir. Dis. 148, 1474-1478 (1993).
64. Haldar, P. et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. New Engl. J. Med. 360, 973-984 (2009).
65. Mittrücker, H. W. et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540-543 (1997).